title: [Metabolism of 7,12-dimethylbenz(alpha)anthracene in vivo].
abstract: The metabolism of 7,12-dimethylbenz(alpha) anthracene (DMBA) was studied, using labelled DMBA-H3, after intravenous injection of the carcinogen in female animals. The maximum excretion of the metabolites took place during the period ranging from 6 to 24 hours. The content of liposoluble metabolites in the urine was insignificant (about 6%), whereas in feces it was much higher (about 40%). Among the metabolites in feces the content of DMBA, 12-hydroxymethyl-7-methylbenz(alpha)anthracene and unidentified DMBA metabolite was significantly high. The content of 7-hydroxymethyl-12-methylbenz(alpha) anthracene fails to show any significant level.
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000032:analysis / Q000378:metabolism* / Q000652:urine; D000818:Animals; D001551:Benz(a)Anthracenes / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D005260:Female; D007275:Injections, Intravenous; D051381:Rats
chemical_list: D001551:Benz(a)Anthracenes; D015127:9,10-Dimethyl-1,2-benzanthracene
vernacular_title: Izuchenie metabolizma 7,12-dimetilbenz(alpha)antratsena in vivo